Lung surfactant(LS) is a mixture of several lipids and four apolipoproteins(SP-A,
-B, -C and -D) and lowers surface tension at air-liquid interface of alveoli.
Most of LS is synthesized and secreted by alveolar type II cells. Although
lamellar bodies are storage granules of LS, each component appears to take
independent intracellular routes to reside in the granules. Patients with
infantile respiratory distress syndrome(IRDS) or acute respiratory distress
syndrome(ARDS) develop fatal respiratory failure due to lack of LS. In
addition, acute phase of interstitial pneumonia also shows deterioration
of LS and increased alveolar surface force resulting in decreased lung
compliance. SP-A and SP-D are used as serum marker to evaluated activity
of interstitial lung diseases. Recently, growing evidences are accumulating
that LS plays a role in innate host defense in the lung against large species
of bacteria, mycoplasma, and viruses.
[Rinsho Byori 50 : 365〜369, 2002]
*Department of Respiratory Medicine, Kanazawa Medical University, Ishikawa-pref. 920-0293
【Key Words】lung surfactant(肺サーファクタント),surface tension(表面張力),alveolar type II cells(肺胞II 型上皮細胞),interstitial lung disease(間質性肺疾患)
*金沢医科大学呼吸器内科(〒920-0293 石川県河北郡内灘町大学1-1)
E-mail :k-osanai@kanazawa-med.ac.jp